Compounding Pharmacies Market Segmentation:
Therapeutic Area Segment Analysis
The global compounding pharmacies market is segmented and analyzed for demand and supply by therapeutic area into pain management, hormone replacement therapy, dermal disorders, and nutritional supplements. Out of which, the pain management segment is anticipated to garner the highest revenue by the end of 2035. The growth of the segment can be attributed to growing prevalence of chronic pain among people. Chronic pain is one of the most common among adults. For instance, the 2019 National Health Interview Survey (NHIS) data were utilized by the Centers for Disease Control and Prevention (CDC) to estimate that 50.2 million US adults suffer from chronic pain. Chronic pain is persistent pain that lasts longer than the typical healing time or coexists with a chronic health condition, such as arthritis. Chronic pain could be ongoing or intermittent. It leads to one inability to work and eat properly, or engage in physical activity. Hence, its treatment is necessary. Oral painkillers are frequently used to treat it, however not everyone may find these to be the most effective. People's experiences with chronic pain might differ greatly from one another, thus for some, the personalized approach provided by pain management compounding may be a preferable choice.
Route of Administration Segment Analysis
The global compounding pharmacies market is also segmented and analyzed for demand and supply by route of administration into oral and topical. Amongst which, the oral segment is anticipated to have a significant growth over the forecast period. Orally administered medications frequently pass through the liver and gut wall, which both have a number of enzymes that render them inactive. This procedure is referred to as "first-pass" or "pre-systemic" metabolism. This demonstrates that, after being administered, only a small percentage of the medicine really penetrates the systemic circulation. Moreover, there is less risk of an acute medication reaction since no sterile measures are required. These favorable aspects have increased the use of oral drugs over others, and even patients prefer them over other forms of treatment.
Our in-depth analysis of the global market includes the following segments:
|
By Therapeutic Area |
|
|
By Route of Administration |
|
|
By Sterility |
|
